Alzheimer's Disease: Drugs
Commons · Question 50810 · Tabled 7 May 2025 · Department of Health and Social Care · Official record
Answered 14 May 2025
Question
Asked by Gregory Stafford
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that (a) Lecanemab and (b) other new treatments for Alzheimer’s disease are made accessible to eligible patients through the NHS.
Answer
Answered by Karin Smyth, 14 May 2025
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service in England on whether new medicines should be routinely funded based on an assessment of their costs and benefits. The NICE evaluates all ne...